Allergy Therapeutics Plc

(LSE) AGY

Current Price£0.07

Market Cap£473.67M

Since IPO (2004)-78%

5 Year-100%

1 Year+4%

1 Month-26%

Allergy Therapeutics Plc Financials at a Glance

Market Cap

£473.67M

Revenue (TTM)

£112.95M

Net Income (TTM)

-£84.62M

EPS (TTM)

-£0.01

P/E Ratio

-7.56

Dividend

£0.00

Beta (Volatility)

0.11 (Low)

Dividend

£0.00

Beta (Volatility)

0.11 (Low)

Price

£0.07

Volume

82,038

Open

£0.08

Price

£0.07

Volume

82,038

Open

£0.08

Previous Close

£0.07

Daily Range

£0.07 - £0.08

52-Week Range

£0.07 - £0.12

Estimated Earnings Date

Sep 24, 2026

Dividend

£0.00

Beta (Volatility)

0.11 (Low)

Price

£0.07

Volume

82,038

Open

£0.08

Previous Close

£0.07

Daily Range

£0.07 - £0.08

52-Week Range

£0.07 - £0.12

Estimated Earnings Date

Sep 24, 2026

AGY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Allergy Therapeutics Plc

Industry

Pharmaceuticals

Sector

Health Care

Employees

612

CEO

Manuel Llobet, MBA

Website

www.allergytherapeutics.com

Headquarters

Worthing, BN14 8SA, GB

AGY Financials

Key Financial Metrics (TTM)

Gross Margin

41%

Operating Margin

-60%

Net Income Margin

-85%

Return on Equity

Return on Capital

-89%

Return on Assets

-69%

Earnings Yield

-13.23%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£473.67M

Shares Outstanding

6.33B

Volume

82.04K

Avg. Volume

258.01K

Financials (TTM)

Gross Profit

£25.13M

Operating Income

-£29.51M

EBITDA

-£29.43M

Operating Cash Flow

-£28.72M

Capital Expenditure

-£3.26M

Free Cash Flow

-£31.98M

Cash & ST Invst.

£12.79M

Total Debt

£60.09M

Allergy Therapeutics Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

£36.28M

+8.1%

Gross Profit

£19.32M

-5.8%

Gross Margin

53.26%

N/A

Market Cap

£473.67M

N/A

Market Cap/Employee

£773.98K

N/A

Employees

612

N/A

Net Income

-£19.92M

-27.3%

EBITDA

-£9.76M

-0.6%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

£10.08M

-25.4%

Total Debt

£26.75M

+171.6%

Accounts Receivable

£10.98M

+10.5%

Inventory

£13.79M

+15.9%

Long Term Debt

£24.79M

+206.0%

Short Term Debt

£1.96M

+12.2%

Return on Assets

-68.96%

N/A

Return on Invested Capital

-88.54%

N/A

Free Cash Flow

-£14.52M

-14.9%

Operating Cash Flow

-£11.71M

-8.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AMS.LAdvanced Medical Solutions Group plc

AMS.LAdvanced Medical Solutions Group plc£2.33+1.97%

AVCT.LAvacta Group Plc

AVCT.LAvacta Group Plc£0.74+0.99%

PRTC.LPureTech Health plc

PRTC.LPureTech Health plc£1.31+0.46%

NIOX.LNIOX Group Plc

NIOX.LNIOX Group Plc£0.56-0.71%

ANCR.LAnimalcare Group plc

ANCR.LAnimalcare Group plc£3.32+0.24%

BXP.LBeximco Pharmaceuticals Limited

BXP.LBeximco Pharmaceuticals Limited£0.43+0.00%

STX.LShield Therapeutics plc

STX.LShield Therapeutics plc£0.06+1.41%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$185.00-0.04%

MRVLMarvell Technology

MRVLMarvell Technology$310.58+0.07%

NOKNokia

NOKNokia$13.49-0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$15.99+0.04%

TAT&T

TAT&T$22.01-0.02%

QSQuantumScape

QSQuantumScape$8.04+0.17%

SOFISoFi Technologies

SOFISoFi Technologies$17.91+0.03%

Questions About AGY

What is the current price of Allergy Therapeutics Plc?

Allergy Therapeutics Plc is trading at £0.07 per share.

What is the 52-week range for Allergy Therapeutics Plc?

Over the past 52 weeks, Allergy Therapeutics Plc has traded between £0.07 and £0.12.

How much debt does Allergy Therapeutics Plc have?

As of the most recent reporting period, Allergy Therapeutics Plc reported total debt of £60.09M.

How much cash does Allergy Therapeutics Plc have on hand?

Allergy Therapeutics Plc reported £12.79M in cash and cash equivalents in its most recent financial results.

What is Allergy Therapeutics Plc’s dividend yield?

Allergy Therapeutics Plc does not currently have a dividend yield.

Allergy Therapeutics Plc

Allergy Therapeutics Plc Financials at a Glance

AGY News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Allergy Therapeutics Plc

AGY Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Allergy Therapeutics Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About AGY

What is the current price of Allergy Therapeutics Plc?

What is the 52-week range for Allergy Therapeutics Plc?

How much debt does Allergy Therapeutics Plc have?

How much cash does Allergy Therapeutics Plc have on hand?

What is Allergy Therapeutics Plc’s dividend yield?

Premium Investing Services